Hypersensitivity pneumonitis is a lung disease triggered when the immune system overreacts to inhaled particles, usually organic dusts, molds, or certain chemicals. The resulting inflammation spreads through the small airways and surrounding lung tissue, and if the exposure continues or the disease goes unrecognized, it can progress to permanent scarring known as fibrosis. HP has historically gone by the name “extrinsic allergic alveolitis” and has been linked to dozens of specific triggers, from bird droppings to contaminated hot tubs, making it one of the more detective-work-intensive diagnoses in pulmonary medicine.
What Triggers HP
The classic culprits are proteins shed by birds and mold spores growing in damp environments. “Bird fancier’s lung” develops from exposure to feather dust and droppings from pigeons, parakeets, or chickens. “Farmer’s lung” comes from inhaling thermophilic bacteria or fungal spores in moldy hay or grain. These two forms account for a large share of recognized cases, but the list of potential triggers has grown considerably.
Metalworking fluid exposure has become the most commonly recognized cause of occupational HP, having been rare before the year 2000. The fluids themselves are complex mixtures, and the offending agent in any given case could be bacteria, mycobacteria, fungi, biocides, emulsifiers, or dissolved metals like chromium and cobalt.1PubMed. Hypersensitivity Pneumonitis Due to Metalworking Fluid Aerosols Hot tub lung is another relatively recently described form, thought to result from a hypersensitivity response to non-tuberculous mycobacteria that thrive in warm, aerated water.2PubMed Central. Hot Tub Lung: A Diagnostic Challenge Other documented triggers include mold in water-damaged buildings, isocyanates in paint and foam manufacturing, and certain pharmaceutical dusts.
The sheer variety of possible antigens makes exposure history the single most important step in evaluation. A person working with metalworking fluids, keeping birds at home, using a hot tub, or living in a home with visible mold and recurrent dampness all have very different source investigations ahead of them. In a substantial fraction of cases, no specific antigen is ever identified, which complicates both diagnosis and management.
How the Immune System Responds
HP involves an unusual combination of immune reactions. The pathogenesis includes both immune-complex-mediated responses and T-cell-driven inflammation.3Current Opinion in Pulmonary Medicine. Hypersensitivity pneumonitis Early understanding framed the disease as a straightforward allergic reaction, but research has revealed a more complex inflammatory process than that simple model suggested.4PubMed. Hypersensitivity pneumonitis In practical terms, what happens is that the inhaled particles provoke an immune response that causes inflammation in the lung’s small airways and the tissue surrounding the air sacs. If the process continues, it can progress from pure inflammation to fibrosis, where the lung tissue stiffens with scar tissue and loses its ability to exchange oxygen efficiently.
Fibrotic Versus Nonfibrotic HP
For decades, clinicians divided HP into acute, subacute, and chronic stages based on how quickly symptoms appeared. That system has largely been replaced. An international guideline from the American Thoracic Society, the Japanese Respiratory Society, and the Latin American Thoracic Association concluded that the old three-stage classification was not easily demarcated and had been applied inconsistently across studies. Because the presence of fibrosis on imaging or biopsy is the primary determinant of prognosis, the guideline committee unanimously recommended classifying HP as either fibrotic or nonfibrotic.5American Journal of Respiratory and Critical Care Medicine. Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline
Nonfibrotic HP is purely inflammatory. When the trigger is identified and removed, these patients generally recover without lasting damage. Fibrotic HP, on the other hand, means scarring has already set in. It can be mixed inflammatory and fibrotic, or purely fibrotic, and carries a worse long-term outlook. This reclassification has real clinical weight: the treatment strategy, the urgency of finding and eliminating the trigger, and the conversation about prognosis all pivot on whether fibrosis is present.
How HP Is Diagnosed
There is no single test that confirms HP. Diagnosis requires pulling together a detailed exposure history, imaging findings, and sometimes airway sampling or lung biopsy, ideally discussed in a multidisciplinary team of pulmonologists, radiologists, and pathologists.6PubMed Central. Diagnosis, course and management of hypersensitivity pneumonitis
CT Imaging
High-resolution CT scanning is the cornerstone imaging tool. In the nonfibrotic form, the classic pattern includes ground-glass opacities (hazy areas where the lung looks foggy rather than clear), small poorly defined nodules centered around airways, and a patchwork pattern called mosaic attenuation where some areas of lung appear lighter than others. On scans taken during exhalation, air trapping in certain lung regions rounds out the picture.7PubMed. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings In fibrotic HP, the scan may also show signs of scarring such as traction bronchiectasis or honeycombing, which overlap substantially with other fibrotic lung diseases.
Separating fibrotic HP from idiopathic pulmonary fibrosis (IPF) on imaging is one of the trickier problems in chest radiology. Low-density lung regions and air trapping, once thought to be distinguishing features, turn out to be present in up to half of IPF patients as well. However, a specific pattern called the “headcheese sign,” where areas of ground-glass opacity, normal lung, and trapped air sit side by side, has been found to be highly specific for fibrotic HP with moderate sensitivity.8European Respiratory Journal. Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis
Bronchoalveolar Lavage
Bronchoalveolar lavage, where saline is flushed into a segment of the lung and then suctioned back for analysis, can provide useful information. A high percentage of lymphocytes in the lavage fluid has traditionally been considered a hallmark of HP, with a threshold of 30% often cited. But the picture is muddier than that simple cutoff suggests. In fibrotic HP, only about a quarter to two-thirds of patients actually cross that threshold, depending on the study and population.9PubMed Central. Bronchoalveolar lavage lymphocytosis in hypersensitivity pneumonitis: a retrospective cohort analysis with elimination of incorporation bias One study found that a lymphocyte percentage above 20% increased by 25 times the odds of a fibrotic HP diagnosis compared to IPF, making lavage analysis particularly useful when the imaging distinction between the two is uncertain.10PubMed Central. Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis Higher lavage lymphocyte counts have also been associated with lower mortality, suggesting they may reflect a more inflammation-dominant and potentially treatable disease process.11PubMed Central. Bronchoalveolar lavage lymphocytosis in hypersensitivity pneumonitis: a retrospective cohort analysis with elimination of incorporation bias
Blood Antibody Tests
Serum precipitins, blood tests that look for antibodies against specific antigens, are often ordered during an HP workup. Their reputation, however, exceeds their performance. Estimated sensitivity falls somewhere between roughly 55% and 72%, and specificity hovers around 61% to 68%, depending on the diagnostic reference standard used.12PubMed Central. Utility of precipitating antibody testing in the diagnostic evaluation of chronic hypersensitivity pneumona That means a negative result does not rule HP out, and a positive result does not confirm it. A separate study found poor agreement between antibody panel results and the patient’s actual exposure history, and the panels did not meaningfully change diagnostic confidence compared to a thorough history alone.13PubMed Central. Serum Specific Antibodies Do Not Seem to Have an Additional Role in the Diagnosis of Hypersensitivity Pneumonitis The upshot: antibody tests may support a clinical suspicion when positive, but a careful exposure history is far more valuable than any blood test for identifying the culprit antigen.
Lung Biopsy and Histopathology
When imaging and lavage results are inconclusive, a lung biopsy may be needed. The histological hallmarks of HP include chronic inflammation centered around small airways, poorly formed small granulomas that do not show the tissue death seen in infections, and patches of organizing pneumonia.14European Respiratory Review. Differential diagnosis of granulomatous lung disease: clues and pitfalls Isolated multinucleated giant cells and varying degrees of interstitial fibrosis may also be present.15PubMed. Granulomas and giant cells in hypersensitivity pneumonitis Even with biopsy, misdiagnosis is not uncommon. One series of patients who ultimately received a fibrotic HP diagnosis through transbronchial cryobiopsy found that several had previously been labeled as having IPF, unclassifiable fibrosis, or even tuberculosis.16Wiley Online Library. Features of transbronchial lung cryobiopsy-diagnosed fibrotic hypersensitivity pneumonitis
Treatment Starts With Removing the Trigger
The most important intervention in HP is identifying and eliminating the antigen source. In nonfibrotic disease, this can be curative. One study followed patients with nonfibrotic HP and found that those who achieved complete antigen avoidance experienced no recurrence and did not develop fibrosis. Among those with incomplete avoidance, over half had recurrences or progressed to fibrosis.17PubMed Central. Antigen avoidance and outcome of nonfibrotic and fibrotic hypersensitivity pneumonitis Even in fibrotic HP, where the damage cannot be fully reversed, research suggests that antigen identification and avoidance remain associated with improved outcomes.18PubMed. Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis
In practice, complete avoidance is not always straightforward. Giving up a pet bird or changing jobs represents a major life disruption. Mold in a home may require extensive and expensive remediation. And when the specific antigen is never identified, you cannot avoid what you have not found. These realities mean that pharmacological treatment is often needed alongside environmental changes.
Drug Therapy for HP
When antigen avoidance alone is not enough, or when the disease is progressing despite it, medications enter the picture. Corticosteroids like prednisone have been the traditional first-line drug, used to suppress the inflammatory response. A survey of British specialists found that the choice of initial immunosuppression in progressive HP was fairly evenly split: roughly 46% started with corticosteroids combined with a steroid-sparing immunosuppressant, while about 39% used oral corticosteroids alone. Among the steroid-sparing agents, mycophenolate was the first choice for three-quarters of respondents.19Thorax. How do specialists treat hypersensitivity pneumonitis in britain? Research comparing mycophenolate or azathioprine added to prednisone versus prednisone alone found fewer treatment-related side effects with the combination regimens, with no difference in lung function decline or survival.20PubMed Central. Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis That steroid-sparing benefit matters because long-term prednisone carries its own serious risks, from bone loss and diabetes to infection susceptibility.
For patients with fibrotic HP that continues to progress despite immunosuppression, antifibrotic drugs originally developed for IPF are increasingly used. Nintedanib, a tyrosine kinase inhibitor, was tested in the INBUILD trial across multiple types of progressive fibrosing lung disease. The overall trial showed that nintedanib slowed the rate of lung function decline. The HP subgroup followed the same trend, though the subgroup analysis alone did not reach statistical significance because the trial was not powered for individual diagnoses.21The Lancet Respiratory Medicine. Nintedanib in progressive fibrosing interstitial lung diseases: subgroup analyses by diagnosis in the INBUILD trial A systematic review confirmed that the HP subgroup trended toward benefit with nintedanib, consistent with the overall trial findings.22Annals of the American Thoracic Society. Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis Laboratory work has shown that nintedanib reduces the pro-fibrotic behavior of lung fibroblasts taken from HP patients at concentrations consistent with clinical dosing.23PubMed. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Prognosis and What Drives It
The outlook for HP spans a wide range. People with nonfibrotic disease who achieve complete antigen avoidance often recover fully. At the other end of the spectrum, fibrotic HP can behave much like IPF, with progressive scarring and declining lung function. Several factors are associated with worse survival: older age, more severe breathing impairment at the time of diagnosis, the presence of established fibrosis with honeycombing on CT, and pulmonary hypertension.24European Respiratory Review. Prognostic factors in chronic hypersensitivity pneumonitis A study of long-term outcomes in chronic HP similarly identified low lavage lymphocyte percentages, reduced gas transfer capacity, honeycombing on CT, and a scarring pattern on biopsy as markers of lower survival.25PubMed. Long-term outcomes in chronic hypersensitivity pneumonitis
One interesting nuance is that CT features alone, without biopsy, may not always predict survival as reliably as histological confirmation of fibrosis. A study comparing CT findings with pathological evidence found that while histologic fibrosis was associated with decreased survival, the CT features by themselves were not.26PubMed. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival This does not mean CT is useless, but it does underscore why multidisciplinary discussion matters when determining the degree of fibrosis and its prognostic implications.
Genetic Susceptibility
Not everyone exposed to the same antigen develops HP. In pigeon breeders’ clubs, for example, only a fraction of members develop the disease despite similar exposures, pointing to genetic susceptibility. A recent study identified specific gene variants associated with increased risk of fibrotic HP. The MUC5B variant rs35705950, already well known in IPF research, was found at a much higher frequency among fibrotic HP patients compared to controls (about 41% vs. 12%). Several variants in the TOLLIP gene were also linked to increased susceptibility.27PubMed. Polymorphisms and haplotypes of TOLLIP and MUC5B are associated with susceptibility and survival in patients with fibrotic hypersensitivity pneumonitis This overlap with IPF genetics raises interesting questions about whether fibrotic HP and IPF share a final common pathway toward lung scarring, differing mainly in the initial trigger.
HP in Children
HP was once considered an adult disease because of its strong association with occupational exposures. But it occurs in children as well and is thought to be underrecognized in that population. In kids, the triggers tend to be domestic rather than occupational: birds kept as family pets, mold in the home, and occasionally hobby-related exposures. Children can present across the same disease spectrum as adults, from acute episodes with fever and breathlessness within hours of exposure to chronic forms with gradual exercise intolerance and weight loss.28PubMed. Hypersensitivity pneumonitis in children: clinical features, diagnosis, and treatment Because pediatric pulmonologists may not initially think of HP, diagnosis can be delayed, particularly if no one asks the right environmental questions.
Lung Transplantation and Disease Recurrence
When fibrotic HP progresses to end-stage lung disease despite all available medical therapy, lung transplantation becomes the remaining option. A case series of transplant recipients with HP revealed an unexpected finding: in about 16% of the cases, HP was not diagnosed until pathologists examined the explanted lungs, meaning the disease had been missed during the pre-transplant workup.29PubMed Central. Lung transplantation for hypersensitivity pneumonitis Even more striking, two patients in that series developed recurrent HP in their transplanted lungs, demonstrating that the immune sensitization persists even after the diseased lungs are replaced. This possibility of recurrence in the allograft underscores the importance of antigen identification and avoidance: if the trigger is never found and the patient returns to the same environment after transplant, the new lungs may face the same immune assault that destroyed the original ones.